1. 2015 Cavitation of lung metastases induced by regorafenib in patients with colorectal carcinoma: Data from the phase III CORRECT study. (September 2015) Authors: Ricotta, R.; Verrioli, A.; Ghezzi, S.; Grothey, A.; Cremolini, C.; Argiles, G.; Adenis, A.; Ychou, M.; Barone, C.; Bouchet, O.; Humblet, Y.; Mineur, L.; Sobrero, A.; Peeters, M.; Van Cutsem, E.; Porcu, L.; Amatu, A.; Sartore-Bianchi, A.; Vanzulli, A.; Siena, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2024 Non-interventional study in elderly patients with metastatic colorectal cancer treated with first line bevacizumab combined to chemotherapy in real life: The CASSIOPEE Study - Interim analysis on patients' characteristics. (September 2015) Authors: Francois, E.; Kim, S.; Deplanque, G.; Smith, D.; Gourgou, S.; Rollot-Trad, F.; Gally, S.; Berthier, A.; Mineur, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2090 Prognostic score (REGOSCORE) for survival after Regorafenib (RE) treatment for patients (pts) with pretreated metastatic colorectal cancer (mCRC). (September 2015) Authors: Kramar, A.; Paule, B.; Burtin, P; Tougeron, D.; Desseigne, F.; Dourthe, L.M.; Wallet, J.; Etienne, PL.; Mineur, L.; Becuwe, C.; Maes, P; Dauba, J.; Michel, P; Hollebecque, A.; Linot, B.; Morere, J.F.; Fouchardiere, C. De la; Phelip, J.M.; Andre, T.; Adenis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2095 Survival benefit, safety, and prognostic factors for outcome with Regorafenib (RE) in patients (pts) with pretreated metastatic colorectal cancer (mCRC). Main analyses of the REBECCA study. (September 2015) Authors: Fontaniere, C. De La Fouchardiere; Paule, B.; Burtin, P; Wallet, J.; Tougeron, D.; Dourthe, L.M.; Etienne, P.L.; Mineur, L.; Becuwe, C.; Maes, P.; Dauba, J.; Michel, P.; Wendling, J.L.; Linot, B.; Hollebecque, A.; Clisant, S.; Morere, J.F.; Andre, T.; Phelip, J.M.; Adenis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2130 Tumour response outcomes during the first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab + FOLFIRI. (September 2015) Authors: Karthaus, M.; Hofheinz, R.; Mineur, L.; Letocha, H.; Greil, R.; Thaler, J.; Fernebro, E.; Zhang, Y.; Oliner, K.S.; Demonty, G.; Kohne, C.H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial. (September 2015) Authors: Taieb, J.; Zaanan, A.; Malicot, K. Le; Julie, C.; Blons, H.; Mineur, L.; Tabernero, J.; Mini, E.; Folprecht, G.; Laethem, J.L. Van; Lepage, C.; Emile, J.F.; Laurent-Puig, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of an early active dietary counselling on grade ≥3 toxicity in patients receiving first-line chemotherapy for metastatic colorectal cancer. (September 2018) Authors: Hébuterne, X.; Besnard, I.; François, E.; Bachmann, P.; Mahamat, A. Abakar; Assenat, E.; Akouz, F. Khemissa; Mineur, L.; Seitz, J.-F.; Senesse, P.; Schneider, S.M. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Management and clinical outcome of rectal cancer in patients ≥80 years treated in southern France (PACA region) between 2006 and 2008. Issue 7 (20th September 2013) Authors: Moureau‐Zabotto, L.; Resbeut, M.; Gal, J.; Mineur, L.; Teissier, E.; Hebuterne, X.; Muyldermans, P.; Francois, E.; Chamorey, E.; Gerard, J‐P Journal: Journal of surgical oncology Issue: Volume 108:Issue 7(2013:Dec. 01) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0108 Impact of the Radiation Therapy Quality Assurance in the phase II/III CONCORDE trial. (May 2022) Authors: Lopez, H.; Créhange, G.; Blanc, J.; M'vondo, C.; Pereira, R.; Rio, E.; Peiffert, D.; Gnep, K.; Benezery, K.; Ronchin, P.; Noel, G.; Mineur, L.; Drouillard, A.; Rouffiac, M.; Boustani, J.; Bertaut, A.; Huguet, F. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC-0336 Dose escalated chemoradiotherapy in esophageal cancer : randomized phase 2/3 CONCORDE trial. (August 2021) Authors: Crehange, G.; M'vondo, C.; Bertaut, A.; Pereira, R.; Rio, E.; Peiffert, D.; Gnep, K.; Benezery, K.; Ronchin, P.; Noel, G.; Mineur, L.; Drouillard, A.; Blanc, J.; Rouffiac, M.; Boustani, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗